secwatch.observer — SEC 8-K summary
======================================

Issuer:     BullFrog AI Holdings, Inc. (BFRG)
CIK:        0001829247
Form:       8-K
Filed at:   2024-02-26T23:59:59+00:00
Accession:  0001493152-24-007776
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bullfrog AI Appoints Dr. Thomas W. Chittenden as Chief Scientific Officer
-------------------------------------------------------------------------

- Dr. Chittenden appointed CSO effective February 26, 2024.
- Previously served as CSO and President of R&D at BioAI Health.
- Also founded AI/SciML initiative at HiberCell and consulted at Harvard Medical School.
- Will lead scientific strategy to advance Bullfrog AI's bfLEAP™ AI drug discovery platform.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829247/000149315224007776/0001493152-24-007776-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829247/000149315224007776/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-007776

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer